Shopping Cart 0
Cart Subtotal
USD 0

OraSure Technologies Inc (OSUR)-Product Pipeline Analysis, 2017 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to various hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company OraSure Technologies Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

OraSure Technologies Inc Company Overview 4

OraSure Technologies Inc Company Snapshot 4

OraSure Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4

OraSure Technologies Inc-Pipeline Analysis Overview 7

Business Description 7

OraSure Technologies Inc-Key Facts 8

OraSure Technologies Inc-Major Products and Services 9

OraSure Technologies Inc Pipeline Products by Development Stage 11

OraSure Technologies Inc Ongoing Clinical Trials by Trial Status 13

OraSure Technologies Inc Pipeline Products Overview 15

Next Generation OraQuick Rapid HIV Test 15

Next Generation OraQuick Rapid HIV Test Product Overview 15

OMNIgeneGUT OM-200 16

OMNIgeneGUT OM-200 Product Overview 16

OraQuick In-Home HIV Test 17

OraQuick In-Home HIV Test Product Overview 17

OraQuick In-Home HIV Test Clinical Trial 18

OraQuick Rapid Zika Virus Test 20

OraQuick Rapid Zika Virus Test Product Overview 20

OraSure Technologies Inc-Key Competitors 21

OraSure Technologies Inc-Key Employees 22

OraSure Technologies Inc-Key Employee Biographies 23

OraSure Technologies Inc-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

OraSure Technologies Inc, Recent Developments 25

Mar 01, 2017: OraSure Receives Global Fund Classification to Enable HIV Self-Test Procurement 25

Feb 24, 2017: OraSure Technologies Announces Director Retirement 25

Feb 08, 2017: OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results 25

Feb 06, 2017: OraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA 26

Nov 29, 2016: OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program 27

Nov 29, 2016: Helix Selects DNA Genotek's Oragene Collection Device and GenoFIND Fulfillment Services for Genetic Discovery Applications 27

Nov 15, 2016: OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors 28

Nov 02, 2016: OraSure Announces 2016 Third Quarter Financial Results 28

Aug 29, 2016: DNA Genotek's OMNIgene GUT Kit is Proposed as Standardized Test for Worldwide Studies of the Human Microbiome 29

Aug 23, 2016: HHS awards $7 Million to OraSure to Speed Development of Zika Diagnostic Test 30

Appendix 32

Methodology 32

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

OraSure Technologies Inc Pipeline Products by Equipment Type 5

OraSure Technologies Inc Pipeline Products by Development Stage 11

OraSure Technologies Inc Ongoing Clinical Trials by Trial Status 13


List Of Table

List of Tables

OraSure Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4

OraSure Technologies Inc Pipeline Products by Equipment Type 5

OraSure Technologies Inc Pipeline Products by Indication 6

OraSure Technologies Inc Ongoing Clinical Trials by Trial Status 6

OraSure Technologies Inc, Key Facts 8

OraSure Technologies Inc, Major Products and Services 9

OraSure Technologies Inc Number of Pipeline Products by Development Stage 11

OraSure Technologies Inc Pipeline Products Summary by Development Stage 12

OraSure Technologies Inc Ongoing Clinical Trials by Trial Status 13

OraSure Technologies Inc Ongoing Clinical Trials Summary 14

Next Generation OraQuick Rapid HIV Test-Product Status 15

Next Generation OraQuick Rapid HIV Test-Product Description 15

OMNIgeneGUT OM-200-Product Status 16

OMNIgeneGUT OM-200-Product Description 16

OraQuick In-Home HIV Test-Product Status 17

OraQuick In-Home HIV Test-Product Description 17

OraQuick In-Home HIV Test-Community-based Distribution of Oral HIV Self-testing Kits-a Pilot Intervention and Rapid Impact Evaluation 18

OraQuick In-Home HIV Test-Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention: South Florida Center for Reducing Health Disparities 18

OraQuick In-Home HIV Test-Self-testing for HIV (HIVST) Amongst Urban, Peri-urban and Rural Communities in Zambia, Including a Cluster-randomised Trial of Community-based HIVST Distribution 19

OraQuick Rapid Zika Virus Test-Product Status 20

OraQuick Rapid Zika Virus Test-Product Description 20

OraSure Technologies Inc, Key Employees 22

OraSure Technologies Inc, Key Employee Biographies 23

OraSure Technologies Inc, Other Locations 24

OraSure Technologies Inc, Subsidiaries 24

Glossary 33

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Trinity Biotech Plc, Sequenom Inc, Psychemedics Corp, NeoGenomics Inc, MedMira Inc, Maxim Biomedical Inc, Enzo Biochem Inc, Cerus Corp, Alere Inc, Abiomed Inc, Abaxis Inc